Tokyo, Japan

Alexander Vinogradov

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Tokyo. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Vinogradov. Retrieved from https://idiyas.com/inventor/alexander-vinogradov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Vinogradov: Innovator in Compound Library Development

Introduction

Alexander Vinogradov is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of compound libraries, which are essential for drug discovery and development. His innovative approach has led to the creation of a unique method for producing cyclic compounds.

Latest Patents

Vinogradov holds a patent for a "Compound library and method for producing compound library." This invention provides a method for producing a compound library comprising two or more cyclic compounds. The process involves allowing a macrocyclase in vitro to act on specific peptides, resulting in the formation of nitrogen-containing 6-membered rings.

Career Highlights

Vinogradov is affiliated with The University of Tokyo, where he continues to advance research in his field. His work has garnered attention for its potential applications in pharmaceuticals and biotechnology.

Collaborations

He has collaborated with esteemed colleagues, including Hiroaki Suga and Yuki Goto, who share his passion for innovation in compound development.

Conclusion

Alexander Vinogradov's contributions to the field of compound libraries exemplify the importance of innovation in scientific research. His work not only enhances our understanding of cyclic compounds but also paves the way for future advancements in drug discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…